Enteralvancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Sizemore, Elizabeth Nicole ^a   Rivas, Kenya Maria ^b   Valdes, Jose ^c   Caballero, Joshua ^d  

^a Asante Health System   (United States)

^b affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

^c BAPTIST HEALTH CARE   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; FLORASTOR; HERBACEOUS AGENT; LINEZOLID; NITROFURANTOIN; NON PRESCRIPTION DRUG; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; PSEUDOMONIC ACID; RIFAMPICIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADVERSE DRUG REACTION; AGED; ANOREXIA; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC SENSITIVITY; APPENDECTOMY; APPENDIX PERFORATION; ARTICLE; CASE REPORT; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FECES ANALYSIS; FOLLOW UP; HUMAN; MALAISE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84865505967     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006366     Document Type: Article

References (39)

1. Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219-26. (Pubitemid 38971493)
2. McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008;3:563-78.
3. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-50.
4. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-9. (Pubitemid 34438842)
5. Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol 2005;100:1828-34. (Pubitemid 41648440)
6. Gravet A, Rondeau M, Harf-Monteil C, et al. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol 1999;37:4012-19.
7. Lo TS, Borchardt SM. Antibiotic-associated diarrhea due to methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2009;63:388-9.
8. APIC. Guide to the elimination of methicillin-resistant Staphylococcus aureus (MRSA) transmission in hospital settings, 2nd edn. 2010. http://www.apic. org/Resource-/EliminationGuideForm/631fcd91-8773-4067-9f85- ab2a5b157eab/File/MRSA-elimination-guide-2010.pdf (accessed 24 Mar 2012).
9. APIC. Guide to the elimination of methicillin-resistant Staphylococcus aureus (MRSA) transmission in long-term care facility. 2009. http://www.apic.org/Resource-/EliminationGuideForm/08b12595-9f92-4a64-ad41- 4afdd0088224/File/APIC-MRSA-in-Long-Term-Care.pdf (accessed 24 Mar 2012).
10. Baldwin NS, Gilpin DF, Hughes CM, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc 2009;57:620-6.
11. Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005;43:5992-5. (Pubitemid 43100649)
12. Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002;30:391-9. (Pubitemid 35316423)
13. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-44. (Pubitemid 34568654)
14. van Saene HKF, Weir WI, de la Cal MA, et al. Enteral vancomycin to control MRSA. J Hosp Infect 2005;59:263-6.
15. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25(Suppl 2):S206-10.
16. Larssen KW, Jacobsen T, Bergh K, et al. Outbreak of methicillin-resistant Staphylococcus aureus in two nursing homes in Central Norway. J Hosp Infect 2005;60:312-6. (Pubitemid 40932085)
17. Rodríguez-Baño J, García L, Ramírez E, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol 2010;31:786-95.
18. Ray AJ, Pultz NJ, Bhalla A, et al. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003;37:875-81. (Pubitemid 37267200)
19. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-55.
20. Loeb MB, Main C, Eady A, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003;4:CD00340.
21. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009;49:935-41.
22. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409-18. (Pubitemid 351665440)
23. Mody L, Kauffman CA, McNeil SA, et al. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:1467-74. (Pubitemid 37494674)
24. Maraha B, van Halteren J, Verzijl JM, et al. Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect 2002;8:671-5. (Pubitemid 35277124)
25. Squier C, Rihs JD, Risa KJ, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002;23:495-501. (Pubitemid 35033858)
26. de la Cal MA, Cerdá E, van Saene HKF, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004;56:175-83. (Pubitemid 38262944)
27. Silvestri L, van Saene HKF, Milanese M, et al. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients: systematic review of randomized, controlled trials. J Hosp Infect 2007;65:187-203.
28. Ochoa-Ardila ME, García-Cañas A, Gómez-Mediavilla K, et al. Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study. Intensive Care Med 2011;37:1458-65.
29. Silvestri L, van Saene HKF, Milanese M, et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 2004;23:921-6. (Pubitemid 38807369)
30. Konishi T, Idezuki Y, Kobayashi H, et al. Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis. J Surg 1997;27:826-32. (Pubitemid 27382704)
31. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86. (Pubitemid 36612323)
32. Daschner F. MRSA: really time for a more pragmatic approach? J Hosp Infect 2005;59:259; author reply 63-6.
33. Quigley EM. Passing the bug-translocation, bacteremia, and sepsis in the intensive care unit patient: is intestinal decontamination the answer? Crit Care Med 2011;39:1202-3.
34. Bhalla A, Aron DC, Donskey CJ. Staphylococcus aureus intestinal colonization is associated with increased frequency of S. aureus on skin of hospitalized patients. BMC Infect Dis 2007;7:105-11.
35. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
36. Williams NT. Probiotics. Am J Health Syst Pharm 2010;67:449-58.
37. McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 2009;15:274-80.
38. Avadhani A, Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults-A meta-analysis. J Am Acad Nurse Pract 2011;23:269-74.
39. Venugopalan V, Shriner KA, Wong-Beringer A. Regulatory oversight and safety of probiotic use. Emerg Infect Dis 2010;16:1661-5.